Oracle (ORCL)

Add to Watchlists
Create an Alert
40.08 -0.05  -0.12% NYSE Apr 17, 8:00PM BATS Real time Currency in USD

Oracle Research and Development Expense (Quarterly):

1.292B for Feb. 28, 2014

View 4,000+ financial data types

View Full Chart

Oracle Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Oracle Historical Research and Development Expense (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Feb. 28, 2014 1.292B
Nov. 30, 2013 1.284B
Aug. 31, 2013 1.237B
May 31, 2013 1.264B
Feb. 28, 2013 1.186B
Nov. 30, 2012 1.211B
Aug. 31, 2012 1.201B
May 31, 2012 1.226B
Feb. 29, 2012 1.145B
Nov. 30, 2011 1.102B
Aug. 31, 2011 1.05B
May 31, 2011 1.17B
Feb. 28, 2011 1.127B
Nov. 30, 2010 1.119B
Aug. 31, 2010 1.103B
May 31, 2010 1.063B
Feb. 28, 2010 823.00M
Nov. 30, 2009 708.00M
Aug. 31, 2009 660.00M
May 31, 2009 730.00M
Feb. 28, 2009 Upgrade
Nov. 30, 2008 Upgrade
Aug. 31, 2008 Upgrade
May 31, 2008 Upgrade
Feb. 29, 2008 Upgrade
   
Nov. 30, 2007 Upgrade
Aug. 31, 2007 Upgrade
May 31, 2007 Upgrade
Feb. 28, 2007 Upgrade
Nov. 30, 2006 Upgrade
Aug. 31, 2006 Upgrade
May 31, 2006 Upgrade
Feb. 28, 2006 Upgrade
Nov. 30, 2005 Upgrade
Aug. 31, 2005 Upgrade
May 31, 2005 Upgrade
Feb. 28, 2005 Upgrade
Nov. 30, 2004 Upgrade
Aug. 31, 2004 Upgrade
May 31, 2004 Upgrade
Feb. 29, 2004 Upgrade
Nov. 30, 2003 Upgrade
Aug. 31, 2003 Upgrade
May 31, 2003 Upgrade
Feb. 28, 2003 Upgrade
Nov. 30, 2002 Upgrade
Aug. 31, 2002 Upgrade
May 31, 2002 Upgrade
Feb. 28, 2002 Upgrade
Nov. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

ORCL Research and Development Expense (Quarterly) Benchmarks

Companies
Microsoft 2.748B
Salesforce.com 173.09M
IBM 1.501B

ORCL Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 660.00M Aug 2009
Maximum 1.292B Feb 2014
Average 1.085B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.